Clinical Trials Browser

Phase 1/2 × Cryosurgery × Thoracic × Clear all

Lung Neoplasms

NCT01065441 2020-01-22

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

BreastDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Melanoma, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT04201990 2019-12-17

CCA-MPLC

Phase 1/2 Unknown

20 enrolled

Thoracic

Lung Neoplasms

NCT02843815 2019-09-12

Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer

Phase 1/2 Completed

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

Safety and Efficiency of γδ T Cell Against Lung Cancer

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

CCA-MPLC

Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer